Clovis Oncology Alternatives & Competitors

9 companies similar to Clovis Oncology

Day One Biopharmaceuticals

Cancer drug development comes of age.

190 Post-IPO Equity $687.50M

Brisbane, United States

Biopharma Biotechnology +2

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company

Accelerating Precision Medicine™

79 Post-IPO Equity $310.00M

Indianapolis, United Stat...

Biopharma Biotechnology +2

Arcus Biosciences

Global, biopharmaceutical company at the forefront of designing precision combinations in...

646 IPO $1.86B

Hayward, United States

Biopharma Biotechnology +3

ALX Oncology

ALX Oncology is a clinical-stage biotechnology company advancing cancer therapies by boost...

63 IPO $525.20M

South San Francisco, Unit...

Biopharma Biotechnology +3

Track all Clovis Oncology competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

EOC Pharma Group

Empowering cancer care in China through a robust network of global partnerships, innovativ...

Series C $532.00M

Biopharma Biotechnology +3

Verastem Oncology

103 Post-IPO Equity $379.10M

Needham, United States

Biopharma Biotechnology +1

MEI Pharma

Committed to the development of novel, best-in-class, cancer therapies intended to provide...

121 Post-IPO Equity $160.36M

San Diego, United States

Biopharma Biotechnology

Newron Pharmaceuticals SpA

The Specialist in CNS Drug Development

23 Post-IPO Equity $129.36M

Bresso, Italy

Biopharma Biotechnology +1

FibroGen, Inc.

Committed to being a place where our people and science thrive.

347 Post-IPO Equity $308.02M

San Francisco, United Sta...

Biopharma Biotechnology +2

About Clovis Oncology

Clovis Oncology, a commercial-stage biotechnology company founded in 2009, is dedicated to advancing the fight against cancer. The company's focus on acquiring, developing, and commercializing cancer treatments in the United States, Europe, and other international markets demonstrates its commitment to improving the li...

Business keywords

Oncology, Cancer Treatments, Precision Medicine, Commercialization, Collaborations, Diagnostic Tools, Regulatory Approvals, Global Commercialization, Management Team, Novel Cancer Therapies, NASDAQ, Boulder, Colorado, International Markets

Frequently Asked Questions

Companies similar to Clovis Oncology include Day One Biopharmaceuticals, POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, Arcus Biosciences, ALX Oncology, EOC Pharma Group. They work in Biopharma and share Clovis Oncology's focus on precision medicine, oncology and commercialization.

Bounce Watch lists 9 companies that share Clovis Oncology's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Clovis Oncology and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Clovis Oncology Profile Day One Biopharmaceuticals Alternatives POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company Alternatives Arcus Biosciences Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Clovis Oncology on 12 Sep 2024. The 9 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.